FullText URL | fulltext.pdf |
---|---|
Author | Kuribayashi, Tadahiro| Kinoshita, Rie| Ninomiya, Kiichiro| Makimoto, Go| Kubo, Toshio| Rai, Kammei| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| Toyooka, Shinichi| Sakaguchi, Masakiyo| Ohashi, Kadoaki| |
Keywords | S100A8/A9 Lung cancer Immune checkpoint inhibitors |
Note | The version of record of this article, first published in Scientific Reports, is available online at Publisher’s website: http://dx.doi.org/10.1038/s41598-025-87232-z| |
Published Date | 2025-01-20 |
Publication Title | Scientific Reports |
Volume | volume15 |
Issue | issue1 |
Publisher | Nature Portfolio |
Start Page | 2577 |
ISSN | 2045-2322 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The Author(s) 2025 |
File Version | publisher |
PubMed ID | 39833332 |
DOI | 10.1038/s41598-025-87232-z |
Web of Science KeyUT | 001400880600002 |
Related Url | isVersionOf https://doi.org/10.1038/s41598-025-87232-z |
FullText URL | fulltext.pdf |
---|---|
Author | Inukai-Motokura, Yumi| Ninomiya, Kiichiro| Baba, Takahiro| Omori, Hiroki| Takeguchi, Tetsuya| Uno, Mari| Ayada, Yoshiyuki| Tanaka, Takehiro| Maeda, Yoshinobu| Ohashi, Kadoaki| |
Keywords | Pulmonary sclerosing pneumocytoma Ipilimumab Nivolumab Programmed cell death ligand 1 Case report |
Published Date | 2024-11-29 |
Publication Title | International Cancer Conference Journal |
Volume | volume14 |
Issue | issue1 |
Publisher | Springer Science and Business Media LLC |
Start Page | 60 |
End Page | 63 |
ISSN | 2192-3183 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The Author(s) 2024 |
File Version | publisher |
DOI | 10.1007/s13691-024-00737-8 |
Web of Science KeyUT | 001366705400001 |
Related Url | isVersionOf https://doi.org/10.1007/s13691-024-00737-8 |
FullText URL | fulltext.pdf |
---|---|
Author | Matsuura, Hiroaki| Makimoto, Go| Oda, Naohiro| Ninomiya, Kiichiro| Higo, Hisao| Fujii, Masanori| Rai, Kammei| Ichihara, Eiki| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| |
Keywords | NUT carcinoma BRD4-NUTM1 lung cancer alpha-fetoprotein (AFP) immune checkpoint inhibitor |
Published Date | 2024-10-01 |
Publication Title | Internal Medicine |
Volume | volume63 |
Issue | issue19 |
Publisher | Japanese Society of Internal Medicine |
Start Page | 2655 |
End Page | 2660 |
ISSN | 0918-2918 |
NCID | AA10827774 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2024 by The Japanese Society of Internal Medicine |
File Version | publisher |
PubMed ID | 38403772 |
DOI | 10.2169/internalmedicine.2938-23 |
Web of Science KeyUT | 001344217900013 |
Related Url | isVersionOf https://doi.org/10.2169/internalmedicine.2938-23 |
FullText URL | fulltext.pdf |
---|---|
Author | Yamashita, Masahiro| Higo, Hisao| Fujii, Nobuharu| Matsumoto, Chiaki| Makimoto, Go| Ninomiya, Kiichiro| Fujii, Masanori| Rai, Kammei| Ichihara, Eiki| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Miyahara, Nobuaki| |
Keywords | Chimeric antigen receptor-T cell therapy Coronavirus disease 2019 Multidrug therapy Organizing pneumonia |
Published Date | 2024 |
Publication Title | Respiratory Medicine Case Reports |
Volume | volume51 |
Publisher | Elsevier |
Start Page | 102104 |
ISSN | 2213-0071 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2024 The Authors. |
File Version | publisher |
DOI | 10.1016/j.rmcr.2024.102104 |
Web of Science KeyUT | 001307936800001 |
Related Url | isVersionOf https://doi.org/10.1016/j.rmcr.2024.102104 |
FullText URL | fulltext20240531-01.pdf |
---|---|
Author | Tanaka, Takaaki| Taoka, Masataka| Makimoto, Go| Ninomiya, Kiichiro| Higo, Hisao| Fujii, Masanori| Ichihara, Eiki| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| |
Keywords | immune checkpoint inhibitor nivolumab ipilimumab cytokine release syndrome immune effector cell-associated neurotoxicity syndrome |
Published Date | 2024-05-01 |
Publication Title | Internal Medicine |
Volume | volume63 |
Issue | issue9 |
Publisher | Japanese Society of Internal Medicine |
Start Page | 1261 |
End Page | 1267 |
ISSN | 0918-2918 |
NCID | AA10827774 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2024 by The Japanese Society of Internal Medicine |
File Version | publisher |
PubMed ID | 37722894 |
DOI | 10.2169/internalmedicine.2429-23 |
Web of Science KeyUT | 001223220900001 |
Related Url | isVersionOf https://doi.org/10.2169/internalmedicine.2429-23 |
FullText URL | fulltext.pdf |
---|---|
Author | Matsuura, Hiroaki| Higo, Hisao| Kuribayashi, Tadahiro| Tamaoki, Akihiko| Nakasuka, Takamasa| Uno, Mari| Makimoto, Go| Ninomiya, Kiichiro| Fujii, Masanori| Rai, Kammei| Ichihara, Eiki| Hotta, Katsuyuki| Miyahara, Nobuaki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| Ohashi, Kadoaki| |
Keywords | case report EGFR-mutated lung cancer osimertinib pulmonary tuberculosis rifampicin |
Published Date | 2024-05-02 |
Publication Title | Thoracic Cancer |
Volume | volume15 |
Issue | issue17 |
Publisher | Wiley |
Start Page | 1390 |
End Page | 1394 |
ISSN | 1759-7706 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2024 The Authors. |
File Version | publisher |
PubMed ID | 38698706 |
DOI | 10.1111/1759-7714.15324 |
Web of Science KeyUT | 001216948400001 |
Related Url | isVersionOf https://doi.org/10.1111/1759-7714.15324 |
FullText URL | fulltext.pdf |
---|---|
Author | Hara, Naofumi| Ichihara, Eiki| Kano, Hirohisa| Ando, Chihiro| Morita, Ayako| Nishi, Tatsuya| Okawa, Sachi| Nakasuka, Takamasa| Hirabae, Atsuko| Abe, Masaya| Asada, Noboru| Ninomiya, Kiichiro| Makimoto, Go| Fujii, Masanori| Kubo, Toshio| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | Epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC) cell cycle CDK4/6 inhibitor |
Published Date | 2023-10-31 |
Publication Title | Translational Lung Cancer Research |
Volume | volume12 |
Issue | issue10 |
Publisher | AME Publishing Company |
ISSN | 2218-6751 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © Translational Lung Cancer Research. |
File Version | publisher |
PubMed ID | 38025818 |
DOI | 10.21037/tlcr-23-99 |
Web of Science KeyUT | 001091030600001 |
Related Url | isVersionOf https://doi.org/10.21037/tlcr-23-99 |
FullText URL | fulltext20240226-04.pdf |
---|---|
Author | Kuribayashi, Tadahiro| Ohashi, Kadoaki| Nishii, Kazuya| Ninomiya, Kiichiro| Tsubata, Yukari| Ishikawa, Nobuhisa| Kodani, Masahiro| Kanaji, Nobuhiro| Yamasaki, Masahiro| Fujitaka, Kazunori| Kuyama, Shoichi| Takigawa, Nagio| Fujimoto, Nobukazu| Kubota, Tetsuya| Inoue, Masaaki| Fujiwara, Keiichi| Harita, Shingo| Takata, Ichiro| Takada, Kenji| Okawa, Sachi| Kiura, Katsuyuki| Hotta, Katsuyuki| |
Keywords | EGFR EGFR-TKI Lung cancer Immune checkpoint inhibitors Performance status |
Note | The version of record of this article, first published in Journal of Cancer Research and Clinical Oncology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s00432-024-05618-4| |
Published Date | 2024-02-12 |
Publication Title | Journal of Cancer Research and Clinical Oncology |
Volume | volume150 |
Issue | issue2 |
Publisher | Springer Science and Business Media LLC |
Start Page | 89 |
ISSN | 1432-1335 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The Author(s) 2024 |
File Version | publisher |
PubMed ID | 38347279 |
DOI | 10.1007/s00432-024-05618-4 |
Web of Science KeyUT | 001160773600002 |
Related Url | isVersionOf https://doi.org/10.1007/s00432-024-05618-4 |
FullText URL | fulltext.pdf |
---|---|
Author | Taoka, Masataka| Makimoto, Go| Umakoshi, Noriyuki| Ninomiya, Kiichiro| Higo, Hisao| Kato, Yuka| Fujii, Masanori| Kubo, Toshio| Ichihara, Eiki| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | Hemoptysis Bronchial artery embolization Endoscopic bronchial occlusion Endobronchial Watanabe Spigot |
Published Date | 2022 |
Publication Title | Respiratory Medicine Case Reports |
Volume | volume38 |
Publisher | Elsevier |
Start Page | 101669 |
ISSN | 2213-0071 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 The Authors. |
File Version | publisher |
PubMed ID | 35646587 |
DOI | 10.1016/j.rmcr.2022.101669 |
Web of Science KeyUT | 001089212200003 |
Related Url | isVersionOf https://doi.org/10.1016/j.rmcr.2022.101669 |
FullText URL | fulltext20231004-03.pdf fig1_20231004-03.pdf fig2_20231004-03.pdf fig3_20231004-03.pdf fig4_20231004-03.pdf fig5_20231004-03.pdf Suppl20231004-03.pdf |
---|---|
Author | Kemmotsu, Naoya| Ninomiya, Kiichiro| Kunimasa, Kei| Ishino, Takamasa| Nagasaki, Joji| Otani, Yoshihiro| Michiue, Hiroyuki| Ichihara, Eiki| Ohashi, Kadoaki| Inoue, Takako| Tamiya, Motohiro| Sakai, Kazuko| Ueda, Youki| Dansako, Hiromichi| Nishio, Kazuto| Kiura, Katsuyuki| Date, Isao| Togashi, Yosuke| |
Keywords | cancer immunotherapy intracranial metastasis intracranial progression memory precursor effector T cell nonsmall-cell lung cancer |
Note | This is the peer reviewed version of the following article: [Kemmotsu N, Ninomiya K, Kunimasa K, et al. Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies. Int J Cancer. 2024; 154(1): 169-179. doi:10.1002/ijc.34700], which has been published in final form at [https://doi.org/10.1002/ijc.34700]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.| This fulltext file will be available in Aug. 2024.| |
Published Date | 2023-08-23 |
Publication Title | International Journal of Cancer |
Volume | volume154 |
Issue | issue1 |
Publisher | Wiley |
Start Page | 169 |
End Page | 179 |
ISSN | 0020-7136 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2023 UICC. |
File Version | author |
PubMed ID | 37611176 |
DOI | 10.1002/ijc.34700 |
Web of Science KeyUT | 001069876600001 |
Related Url | isVersionOf https://doi.org/10.1002/ijc.34700 |
FullText URL | fulltext.pdf |
---|---|
Author | Ando, Chihiro| Ichihara, Eiki| Nishi, Tatsuya| Morita, Ayako| Hara, Naofumi| Takada, Kenji| Nakasuka, Takamasa| Watanabe, Hiromi| Kano, Hirohisa| Nishii, Kazuya| Makimoto, Go| Kondo, Takumi| Ninomiya, Kiichiro| Fujii, Masanori| Kubo, Toshio| Ohashi, Kadoaki| Matsuoka, Ken-Ichi| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | alectinib ALK gilteritinib non-small cell lung cancer TKI |
Published Date | 2023-09-15 |
Publication Title | Cancer Science |
Volume | volume114 |
Issue | issue11 |
Publisher | Wiley |
Start Page | 4343 |
End Page | 4354 |
ISSN | 1347-9032 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2023 The Authors. |
File Version | publisher |
PubMed ID | 37715310 |
DOI | 10.1111/cas.15958 |
Web of Science KeyUT | 001067479000001 |
Related Url | isVersionOf https://doi.org/10.1111/cas.15958 |
FullText URL | fulltext20230421-01.pdf figure20230421-01.pdf |
---|---|
Author | Nakasuka, Takamasa| Ohashi, Kadoaki| Nishii, Kazuya| Hirabae, Atsuko| Okawa, Sachi| Tomonobu, Nahoko| Takada, Kenji| Ando, Chihiro| Watanabe, Hiromi| Makimoto, Go| Ninomiya, Kiichiro| Fujii, Masanori| Kubo, Toshio| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Kumon, Hiromi| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | EGFR mutation Non-small cell lung cancer Antitumor immunity Non-inflamed tumor Ad-SGE-REIC Gene therapy PD-1 |
Note | ©2023 Elsevier B.V. This manuscript version is made available under the CC-BY-NC-ND 4.0 License. http://creativecommons.org/licenses/by-nc-nd/4.0/. This is the accepted manuscript version. The formal published version is available at https://doi.org/10.1016/j.lungcan.2023.01.018.| This fulltext file will be available in Apr. 2024.| |
Published Date | 2023-04 |
Publication Title | Lung Cancer |
Volume | volume178 |
Publisher | Elsevier BV |
Start Page | 1 |
End Page | 10 |
ISSN | 0169-5002 |
NCID | AA10785743 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2023 Elsevier B.V. |
File Version | author |
PubMed ID | 36753780 |
DOI | 10.1016/j.lungcan.2023.01.018 |
Web of Science KeyUT | 000931976300001 |
Related Url | isVersionOf https://doi.org/10.1016/j.lungcan.2023.01.018 |
FullText URL | fulltext.pdf |
---|---|
Author | Makimoto, Go| Shimonishi, Atsushi| Ohashi, Kadoaki| Ninomiya, Kiichiro| Higo, Hisao| Kato, Yuka| Fujii, Masanori| Kubo, Toshio| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | MET Tepotinib Non-small-cell lung cancer |
Published Date | 2022 |
Publication Title | Case Reports In Oncology |
Volume | volume15 |
Issue | issue2 |
Publisher | Karger |
Start Page | 494 |
End Page | 498 |
ISSN | 1662-6575 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 The Author(s). |
File Version | publisher |
PubMed ID | 35702678 |
DOI | 10.1159/000524326 |
Web of Science KeyUT | 000864085100005 |
Related Url | isVersionOf https://doi.org/10.1159/000524326 |
FullText URL | fulltext.pdf |
---|---|
Author | Ando, Eri| Nakasuka, Takamasa| Kubo, Toshio| Taniguchi, Akihiko| Ninomiya, Kiichiro| Kato, Yuka| Ichihara, Eiki| Ohashi, Kadoaki| Rai, Kammei| Hotta, Katsuyuki| Yamane, Masaomi| Miyahara, Nobuaki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | pulmonary aspergilloma allergic bronchopulmonary aspergillosis disaster |
Published Date | 2022-02-01 |
Publication Title | Internal Medicine |
Volume | volume61 |
Issue | issue3 |
Publisher | JAPAN SOC INTERNAL MEDICINE |
Start Page | 379 |
End Page | 383 |
ISSN | 0918-2918 |
NCID | AA10827774 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2022 The Japanese Society of Internal Medicine |
File Version | publisher |
PubMed ID | 34373373 |
DOI | 10.2169/internalmedicine.7124-21 |
Web of Science KeyUT | 000752787300015 |
Related Url | isVersionOf https://doi.org/10.2169/internalmedicine.7124-21 |
FullText URL | fulltext.pdf |
---|---|
Author | Higo, Hisao| Ohashi, Kadoaki| Tomida, Shuta| Okawa, Sachi| Yamamoto, Hiromasa| Sugimoto, Seiichiro| Senoo, Satoru| Makimoto, Go| Ninomiya, Kiichiro| Nakasuka, Takamasa| Nishii, Kazuya| Taniguchi, Akihiko| Kubo, Toshio| Ichihara, Eiki| Hotta, Katsuyuki| Miyahara, Nobuaki| Maeda, Yoshinobu| Toyooka, Shinichi| Kiura, Katsuyuki| |
Keywords | Idiopathic pulmonary fibrosis RNA sequencing Molecular therapeutic target Personalized therapy |
Published Date | 2022-02-07 |
Publication Title | Respiratory Research |
Volume | volume23 |
Issue | issue1 |
Publisher | BMC |
Start Page | 20 |
ISSN | 1465-993X |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The Author(s) 2022. |
File Version | publisher |
PubMed ID | 35130915 |
DOI | 10.1186/s12931-022-01940-y |
Web of Science KeyUT | 000752386100002 |
Related Url | isVersionOf https://doi.org/10.1186/s12931-022-01940-y |
FullText URL | fulltext.pdf |
---|---|
Author | Okawa, Sachi| Rai, Kammei| Fujii, Nobuharu| Gion, Yuka| Ninomiya, Kiichiro| Kato, Yuka| Taniguchi, Akihiko| Kubo, Toshio| Ichihara, Eiki| Ohashi, Kadoaki| Miyahara, Nobuaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | EGFR IgG4-related disease marginal zone lymphoma osimertinib |
Published Date | 2021-09-01 |
Publication Title | Internal Medicine |
Volume | volume60 |
Issue | issue17 |
Publisher | The Japanese Society of Internal Medicine |
Start Page | 2831 |
End Page | 2837 |
ISSN | 0918-2918 |
NCID | AA10827774 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2021 The Japanese Society of Internal Medicine |
File Version | publisher |
PubMed ID | 33775999 |
DOI | 10.2169/internalmedicine.6470-20 |
Web of Science KeyUT | 000695856000020 |
Related Url | isVersionOf https://doi.org/10.2169/internalmedicine.6470-20 |
FullText URL | fulltext20210810-3.pdf |
---|---|
Author | Nishii, Kazuya| Ohashi, Kadoaki| Watanabe, Hiromi| Makimoto, Go| Nakasuka, Takamasa| Higo, Hisao| Ninomiya, Kiichiro| Kato, Yuka| Kubo, Toshio| Rai, Kammei| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | epidermal growth factor receptor osimertinib bevacizumab cetuximab hypoxia‑inducible factor‑1α transforming growth factor‑α |
Published Date | 2021-7-7 |
Publication Title | Oncology Letters |
Volume | volume22 |
Issue | issue3 |
Publisher | Spandidos Publications |
Start Page | 639 |
ISSN | 1792-1074 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © Nishii et al. This is an open access article distributed under the terms of Creative Commons Attribution License. |
File Version | publisher |
DOI | 10.3892/ol.2021.12900 |
Web of Science KeyUT | 000678494600001 |
Related Url | isVersionOf https://doi.org/10.3892/ol.2021.12900 |
FullText URL | fulltext.pdf |
---|---|
Author | Watanabe, Hiromi| Ichihara, Eiki| Kayatani, Hiroe| Makimoto, Go| Ninomiya, Kiichiro| Nishii, Kazuya| Higo, Hisao| Ando, Chihiro| Okawa, Sachi| Nakasuka, Takamasa| Kano, Hirohisa| Hara, Naofumi| Hirabae, Atsuko| Kato, Yuka| Ninomiya, Takashi| Kubo, Toshio| Rai, Kammei| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Published Date | 2021-01-07 |
Publication Title | Cancer science |
Publisher | Wiley |
ISSN | 1347-9032 |
NCID | AA11808050 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © 2021 The Authors. |
File Version | publisher |
PubMed ID | 33410241 |
NAID | 120007008532 |
DOI | 10.1111/cas.14801 |
Web of Science KeyUT | 000630136900001 |
Related Url | isVersionOf https://doi.org/10.1111/cas.14801 |
FullText URL | fulltext.pdf |
---|---|
Author | Nishii, Kazuya| Ohashi, Kadoaki| Tamura, Tomoki| Ninomiya, Kiichiro| Matsubara, Takehiro| Senoo, Satoru| Kano, Hirohisa| Watanabe, Hiromi| Oda, Naohiro| Makimoto, Go| Higo, Hisao| Kato, Yuka| Ninomiya, Takashi| Kubo, Toshio| Yamamoto, Hiromasa | Tomida, Shuta| Hotta, Katsuyuki| Tabata, Masahiro| Toyooka, Shinichi| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Keywords | non-small cell lung cancer epidermal growth factor receptor mutations droplet digital PCR exhaled breath condensate EGFR-TKIs |
Published Date | 2020-12 |
Publication Title | Oncology Letters |
Volume | volume20 |
Issue | issue6 |
Publisher | Spandidos Publications |
Start Page | 393 |
ISSN | 1792-1074 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
File Version | publisher |
PubMed ID | 33193853 |
DOI | 10.3892/ol.2020.12256 |
Web of Science KeyUT | 000595649300005 |
Related Url | isVersionOf https://doi.org/10.3892/ol.2020.12256 |
JaLCDOI | 10.18926/AMO/60796 |
---|---|
FullText URL | 74_5_371.pdf |
Author | Makimoto, Go| Ohashi, Kadoaki| Maeda, Yoshinobu| Kiura, Katsuyuki| |
Abstract | The prognosis of advanced non-small cell lung cancer (NSCLC) patients has improved in recent decades, especially for patients with an oncogenic driver mutation. Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) are effective for patients with the echinoderm microtubule-associated protein-like 4-ALK fusion gene. Several ALK-TKIs have been established: the first-generation ALK-TKI, crizotinib; second-generation ALK-TKIs, alectinib and ceritinib; and third-generation ALK-TKI, lorlatinib. Some ALK-TKIs are effective for tumors that are resistant to other ALK-TKIs; however, as is known in epidermal growth factor receptormutant lung cancer, tumor resistance is inevitable. ALK-positive NSCLCs acquire resistance via various mechanisms, making it a heterogeneous disease. Therefore, it is necessary to develop next-generation treatment strategies, such as the use of next-generation ALK-TKIs for secondary mutations, or combination therapies with ALK-TKIs and other TKIs. In this review, we summarize the development and use of ALK-TKIs, prior pivotal clinical trials, and resistance mechanisms. |
Keywords | lung cancer anaplastic lymphoma kinase tyrosine kinase inhibitors resistance mechanism |
Amo Type | Review |
Publication Title | Acta Medica Okayama |
Published Date | 2020-10 |
Volume | volume74 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 371 |
End Page | 379 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
Copyright Holders | CopyrightⒸ 2020 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 33106692 |
Web of Science KeyUT | 000581970100001 |
NAID | 120006892922 |